42 related articles for article (PubMed ID: 23410059)
21. The Clinical and Pathological Significance of Nectin-2 and DDX3 Expression in Pancreatic Ductal Adenocarcinomas.
Liang S; Yang Z; Li D; Miao X; Yang L; Zou Q; Yuan Y
Dis Markers; 2015; 2015():379568. PubMed ID: 26294807
[TBL] [Abstract][Full Text] [Related]
22. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract][Full Text] [Related]
23. Multiple functions of DDX3 RNA helicase in gene regulation, tumorigenesis, and viral infection.
Ariumi Y
Front Genet; 2014; 5():423. PubMed ID: 25538732
[TBL] [Abstract][Full Text] [Related]
24. High expression of interleukin 10 might predict poor prognosis in early stage oral squamous cell carcinoma patients.
Chen CJ; Sung WW; Su TC; Chen MK; Wu PR; Yeh KT; Ko JL; Lee H
Clin Chim Acta; 2013 Jan; 415():25-30. PubMed ID: 22981868
[TBL] [Abstract][Full Text] [Related]
25. Subsite-specific association of DEAD box RNA helicase DDX60 with the development and prognosis of oral squamous cell carcinoma.
Fu TY; Wu CN; Sie HC; Cheng JT; Lin YS; Liou HH; Tseng YK; Shu CW; Tsai KW; Yen LM; Tseng HW; Tseng CJ; Ger LP; Liu PF
Oncotarget; 2016 Dec; 7(51):85097-85108. PubMed ID: 27835882
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
28. Gender difference in the prognostic role of interleukin 6 in oral squamous cell carcinoma.
Chen CJ; Sung WW; Lin YM; Chen MK; Lee CH; Lee H; Yeh KT; Ko JL
PLoS One; 2012; 7(11):e50104. PubMed ID: 23185547
[TBL] [Abstract][Full Text] [Related]
29. DDX3, a potential target for cancer treatment.
Bol GM; Xie M; Raman V
Mol Cancer; 2015 Nov; 14():188. PubMed ID: 26541825
[TBL] [Abstract][Full Text] [Related]
30. A double-edged function of DDX3, as an oncogene or tumor suppressor, in cancer progression (Review).
He Y; Zhang D; Yang Y; Wang X; Zhao X; Zhang P; Zhu H; Xu N; Liang S
Oncol Rep; 2018 Mar; 39(3):883-892. PubMed ID: 29328432
[TBL] [Abstract][Full Text] [Related]
31. DDX3X Multifunctionally Modulates Tumor Progression and Serves as a Prognostic Indicator to Predict Cancer Outcomes.
Lin TC
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906196
[TBL] [Abstract][Full Text] [Related]
32. Low/negative expression of DDX3 might predict poor prognosis in non-smoker patients with oral cancer.
Lee CH; Lin SH; Yang SF; Yang SM; Chen MK; Lee H; Ko JL; Chen CJ; Yeh KT
Oral Dis; 2014 Jan; 20(1):76-83. PubMed ID: 23410059
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]